Von Seggern Christopher (CIK 0001821192)

Latest company ownership

Role: Chief Commercial Officer
Shares held
4,000
Last filed at
Dec 7, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 6, 2021 Dec 7, 2021 Xenon Pharmaceuticals Inc. Chief Commercial Officer Buy 95.0 +4,000 100.00% $97.6K